Pages
For science or profit?
Helen Palmer Sep 1, 2007
Children's Hospital of Philadelphia plans to create a genetic database of over 100,000 children. The initiative raises questions about privacy and who should profit from such information. Helen Palmer reports.
Hey, those are <em>our</em> ancient remedies!
Sep 1, 2007
American and European drug companies have filed thousands of patents on unorthodox treatments that have been used in India for centuries. Now, India is fighting back to protect its ancient intellectual property. Suzanne Marmion reports.
Glaxo eyeing Pfizer consumer meds
Janet Babin Sep 1, 2007
Bidding is expected to close today for Pfizer's over-the-counter division. The top bidder so far is said to be pharmaceutical giant GlaxoSmithKline. Janet Babin reports.
AIDS at 25
Helen Palmer Sep 22, 2011
The disease has claimed 25 million lives and cost billions of dollars to fight and treat. Helen Palmer looks at what the next 25 years might bring.
New organic rules
Janet Babin Sep 1, 2007
The government this week issues new rules about what food can be labeled organic. Janet Babin has more.
FDA restaurant report
Scott Tong Sep 22, 2011
Government food regulators are expected to release a report today calling on restaurants to give caloric information on their menus. Scott Tong has more.
Fight against AIDS continues
Helen Palmer Sep 22, 2011
After 25 years the spread of AIDS seems to be slowing. But 40 million people are infected with HIV, and unprecedented resources are being spent to keep fighting it. Helen Palmer reports.
FDA approves sale of Merck's shingles vaccine
Hilary Wicai Sep 22, 2011
The Food and Drug Administration has approved a shingles vaccine for older Americans that was developed by the drug company Merck. Hillary Wicai reports.
Inventors beware: Take good notes
Sep 1, 2007
After nearly two decades, the man who invented coronary stents may finally get his due. The device used regularly in heart surgeries has made billions, but Atlanta dentist Henry Wall hasn't seen a dime of it. Emily Kopp reports.
Had any brain-altering stimulants today?
Sep 1, 2007
Commentator Peter Coy says that the use of performance-enhancing drugs in the workplace is on the rise — and that it could drastically alter the business world.
